Loading…
Reported covered position: Intern for Sen. Harry Reid, Jan. - Apr. 2013.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Over-the-Counter Monograph Drug User Fee Amendments
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments H.R. 4273/S. 2292; S. 2529 - The SMART OTC Act; Division F, Title V of The Continuing Appropriations and Extensions Act, 2026 - H.R. 5371; Issues related to consumer health care products supply chain; Issues related to FY2027 appropriations report language.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to VA home health services; Issues related to FY 26 fee schedule; Issues related to H.R. 9752/S. 5027 - Protecting Home-Based Care for Rural Veterans Act of 2026.
Issues related to legislative and regulatory proposals affecting home care and hospice; Issues related to regulations and legislative proposals affecting reimbursement and staffing for home care agencies; Issues related to Medicaid budget reconciliation; Issues related to S. 5250 - Medicare Home Health Payment Integrity and Protection Act of 2026.
Source: Senate LDA
| CELLDEX THERAPEUTICS, INC. |
| 5 |
| 2025–2026 |
| CHRISTUS HEALTH SYSTEM | 5 | 2025–2026 |
| KYVERNA THERAPEUTICS, INC. | 5 | 2025–2026 |
| ALLIANCE FOR AGING RESEARCH | 3 | 2025 |
| QNOVIA, INC. | 2 | 2025 |
| UNITED STATES PHARMACOPEIAL CONVENTION | 2 | 2025 |
| COUPANG INC. | 1 | 2025 |
| KIMBERLY-CLARK CORPORATION | 1 | 2026 |
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments H.R. 4273/S. 2292; S. 2529 - The SMART OTC Act; Division F, Title V of The Continuing Appropriations and Extensions Act, 2026 - H.R. 5371; Issues related to consumer health care products supply chain; Issues related to FY2027 appropriations report language.
State of Men’s Health Act
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status, including Section 304 of H.R. 9393; issues related to consumer health care products supply chain; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Financial Services and General Government Appropriations Act, 2027 (H.R. 8495); State of Men's Health Act (H.R. 7602, S. 5113); GRAS reform; CLEAR LABELS Act (S. 3788, H.R. 8269).
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status, including Section 304 of H.R. 9393; issues related to consumer health care products supply chain; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Financial Services and General Government Appropriations Act, 2027 (H.R. 8495); State of Men's Health Act (H.R. 7602, S. 5113); GRAS reform; CLEAR LABELS Act (S. 3788, H.R. 8269).
Financial Services and General Government Appropriations Act, 2027
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status; Issues related to consumer health care products supply chain; Issues related to FY27 appropriations report language, including H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 and H.R. 8495 - Financial Services and General Government Appropriations Act, 2027.
Financial Services and General Government Appropriations Act, 2027
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status, including Section 304 of H.R. 9393; issues related to consumer health care products supply chain; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Financial Services and General Government Appropriations Act, 2027 (H.R. 8495); State of Men's Health Act (H.R. 7602, S. 5113); GRAS reform; CLEAR LABELS Act (S. 3788, H.R. 8269).
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: BIOSPLICE THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: KYVERNA THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and Multiple Sclerosis; Issues related to H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status; Issues related to consumer health care products supply chain; Issues related to FY27 appropriations report language, including H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 and H.R. 8495 - Financial Services and General Government Appropriations Act, 2027.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status, including Section 304 of H.R. 9393; issues related to consumer health care products supply chain; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Financial Services and General Government Appropriations Act, 2027 (H.R. 8495); State of Men's Health Act (H.R. 7602, S. 5113); GRAS reform; CLEAR LABELS Act (S. 3788, H.R. 8269).
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: BIOSPLICE THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260).
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: KYVERNA THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to developing cell and gene therapies for patients, including Stiff Person Syndrome, rare disease, and multiple sclerosis; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75); Issues related to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues related to H.R.8845 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services and care coordination; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BIOSPLICE THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BIOSPLICE THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75); Issues related to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues related to H.R.8845 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
Lower Costs, More Transparency Act of 2026
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status, including Section 304 of H.R. 9393; issues related to consumer health care products supply chain; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Financial Services and General Government Appropriations Act, 2027 (H.R. 8495); State of Men's Health Act (H.R. 7602, S. 5113); GRAS reform; CLEAR LABELS Act (S. 3788, H.R. 8269).
Protecting Home-Based Care for Rural Veterans Act of 2026
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to VA home health services; Issues related to FY 26 fee schedule; Issues related to H.R. 9752/S. 5027 - Protecting Home-Based Care for Rural Veterans Act of 2026.
Over-the-Counter Monograph Drug User Fee Amendments
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments H.R. 4273/S. 2292; S. 2529 - The SMART OTC Act; Division F, Title V of The Continuing Appropriations and Extensions Act, 2026 - H.R. 5371; Issues related to consumer health care products supply chain; Issues related to FY2027 appropriations report language.
Neonatal Care Transparency Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments H.R. 4273/S. 2292; S. 2529 - The SMART OTC Act; Division F, Title V of The Continuing Appropriations and Extensions Act, 2026 - H.R. 5371; Issues related to consumer health care products supply chain; Issues related to FY2027 appropriations report language.
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status, including Section 304 of H.R. 9393; issues related to consumer health care products supply chain; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Financial Services and General Government Appropriations Act, 2027 (H.R. 8495); State of Men's Health Act (H.R. 7602, S. 5113); GRAS reform; CLEAR LABELS Act (S. 3788, H.R. 8269).
Protecting Home-Based Care for Rural Veterans Act of 2026
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to VA home health services; Issues related to FY 26 fee schedule; Issues related to H.R. 9752/S. 5027 - Protecting Home-Based Care for Rural Veterans Act of 2026.
State of Men’s Health Act
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status, including Section 304 of H.R. 9393; issues related to consumer health care products supply chain; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Financial Services and General Government Appropriations Act, 2027 (H.R. 8495); State of Men's Health Act (H.R. 7602, S. 5113); GRAS reform; CLEAR LABELS Act (S. 3788, H.R. 8269).
Medicare Home Health Payment Integrity and Protection Act of 2026
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to legislative and regulatory proposals affecting home care and hospice; Issues related to regulations and legislative proposals affecting reimbursement and staffing for home care agencies; Issues related to Medicaid budget reconciliation; Issues related to S. 5250 - Medicare Home Health Payment Integrity and Protection Act of 2026.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; Issues related to H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 5342/S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026; H.R. 3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026; Reauthorization proposals in H.R. 2483/S. 2121 - The SUPPORT for Patients and Communities Reauthorization Act of 2025.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; SUPPORT Act reauthorization proposals, including H.R. 2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 5342/S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026; H.R. 3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026; Reauthorization proposals in H.R. 2483/S. 2121 - The SUPPORT for Patients and Communities Reauthorization Act of 2025.
Over-the-Counter Monograph Drug User Fee Amendments
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments (H.R. 4273/S. 2292); Issues related to S. 2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches; Issues related to the Continuing Appropriations and Extensions Act, 2026 (H.R. 5371).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: ALLIANCE FOR AGING RESEARCH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to utilization management and changes to Medicare Part D; Issues related to the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 5342/S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026; H.R. 3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026; Reauthorization proposals in H.R. 2483/S. 2121 - The SUPPORT for Patients and Communities Reauthorization Act of 2025.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 5342/S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026; H.R. 3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026; Reauthorization proposals in H.R. 2483/S. 2121 - The SUPPORT for Patients and Communities Reauthorization Act of 2025.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments (H.R. 4273/S. 2292); Issues related to S. 2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches; Issues related to the Continuing Appropriations and Extensions Act, 2026 (H.R. 5371).
MAPS Act
Client: UNITED STATES PHARMACOPEIAL CONVENTION · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to advanced manufacturing, drug shortages, and pharmaceutical supply chains; Issues related to S.1784 - MAPS Act.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; Issues related to H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 5342/S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026; H.R. 3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026; Reauthorization proposals in H.R. 2483/S. 2121 - The SUPPORT for Patients and Communities Reauthorization Act of 2025.
Over-the-Counter Monograph Drug User Fee Amendments
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments (H.R. 4273/S. 2292); Issues related to S. 2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches; Issues related to the Continuing Appropriations and Extensions Act, 2026 (H.R. 5371).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 5342/S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026; H.R. 3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026; Reauthorization proposals in H.R. 2483/S. 2121 - The SUPPORT for Patients and Communities Reauthorization Act of 2025.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Client: CHATTEM, INC. DBA OPELLA · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments (H.R. 4273/S. 2292); Issues related to S. 2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches; Issues related to the Continuing Appropriations and Extensions Act, 2026 (H.R. 5371).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 5342/S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026; H.R. 3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026; Reauthorization proposals in H.R. 2483/S. 2121 - The SUPPORT for Patients and Communities Reauthorization Act of 2025.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: ALLIANCE FOR AGING RESEARCH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to utilization management and changes to Medicare Part D; Issues related to the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Support for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Better Care Better Jobs Act
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Preserving Access to Home Health Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
SUPPORT for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
SUPPORT for Patients and Communities Reauthorization Act
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act.
Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Client: TEXAS ASSOCIATION FOR HOME CARE & HOSPICE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act.
Issues related to home care and hospice, telehealth, Medicare reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to hospital reimbursement, including sequestration; Issues related to prescription drug pricing; Issues related to surprise billing; Issues related to telehealth; Issues related to 1115 Medicaid Waiver; Issues related to health care workforce; Issues related to maternal health; Issues related to freestanding ERs; Issues related to Medicaid coverage and enrollees and hospital reimbursement.
Issues related to Medicaid; Issues related to hospital reimbursement; Issues related to Children's Hospital GME; Issues related to Disproportionate Share Hospital (DSH) payments; Issues related to site-neutral payment; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to health care workforce; Issues related to hospital reimbursement, rural health, and impacts to low-income populations; Issues related to ACA premium assistance; Issues related to hospital reimbursement and impacts to low-income populations; Issues related to hospital reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KYVERNA THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to developing cell and gene therapies for patients, including Stiff Person Syndrome, rare disease, and multiple sclerosis; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHATTEM, INC. DBA OPELLA via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status, including Section 304 of H.R. 9393; issues related to consumer health care products supply chain; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Financial Services and General Government Appropriations Act, 2027 (H.R. 8495); State of Men's Health Act (H.R. 7602, S. 5113); GRAS reform; CLEAR LABELS Act (S. 3788, H.R. 8269).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOSPLICE THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260).
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to Medicare Advantage compensation and agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to home care and hospice, telehealth, and Medicare reimbursement.
Issues related to home care and hospice; Issues related to reimbursement and staffing for home care agencies; Issues related to Medicaid budget reconciliation.
Issues related to VA home health services; Issues related to the Fiscal Year 2026 Fee Schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
KYVERNA THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and Multiple Sclerosis; Issues related to H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHATTEM, INC. DBA OPELLA via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status; Issues related to consumer health care products supply chain; Issues related to FY27 appropriations report language, including H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 and H.R. 8495 - Financial Services and General Government Appropriations Act, 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELLDEX THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to mast cell conditions and therapies; Issues related to drug development and biopharma ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOSPLICE THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to behavioral health services and care coordination; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75); Issues related to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues related to H.R.8845 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to Medicare Advantage compensation and agent and broker policies; Issues related to MedPAC nominations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to reimbursement and staffing for home care agencies, home care and hospice; Issues related to Medicaid budget reconciliation.
Issues related to home care and hospice, telehealth, and Medicare reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to the National Defense Authorization Act (P.L. 119-60); Issues related to the U.S. Family Health Plan Program.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to hospital reimbursement, including sequestration; Issues related to prescription drug pricing and surprise billing; Issues related to telehealth; Issues related to 1115 Medicaid Waivers; Issues related to maternal health, freestanding ERs, and the health care workforce; Issues related to Medicaid coverage and enrollees; Issues related to hospital reimbursement.
KIMBERLY-CLARK CORPORATION via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to U.S. investment project; Issues related to corporate acquisition.
Issues related to corporate acquisition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KYVERNA THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and Multiple Sclerosis; Issues related to appropriations report language for Fiscal Year 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHATTEM, INC. DBA OPELLA via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments H.R. 4273/S. 2292; S. 2529 - The SMART OTC Act; Division F, Title V of The Continuing Appropriations and Extensions Act, 2026 - H.R. 5371; Issues related to consumer health care products supply chain; Issues related to FY2027 appropriations report language.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
BIOSPLICE THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to appropriations report language for Fiscal Year 2027.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75); Issues related to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to Medicare Program policy for Contract Year 2027 and technical changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program Proposed Rule; Issues related to Fiscal Year 2027 appropriations report language concerning Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS), and Commerce, Justice, Science, and Related Agencies (CJS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to Medicare Advantage compensation and agent and broker policies; Issues related to MedPAC nominations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to home care and hospice, telehealth, and Medicare reimbursement.
Issues related to reimbursement and staffing for home care agencies, home care and hospice; Issues related to Medicaid budget reconciliation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Medicaid, hospital reimbursement, Childrens Hospital GME, Disproportionate Share Hospital payments, and site-neutral payments; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to the health care workforce.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to hospital reimbursement, including sequestration; Issues related to prescription drug pricing and surprise billing; Issues related to 1115 Medicaid Waivers; Issues related to maternal health, freestanding ERs, and the health care workforce; Issues related to Medicaid coverage and enrollees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KYVERNA THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and multiple sclerosis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELLDEX THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to NIH-funded research; Issues related to mast cell conditions and therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOSPLICE THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 5342/S. 2354 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026; H.R. 3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026; Reauthorization proposals in H.R. 2483/S. 2121 - The SUPPORT for Patients and Communities Reauthorization Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · Q4
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOSPLICE THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · RR
Issues related to the development and manufacturing of therapies for osteoarthritis, oncology, and areas of significant unmet medical need.
KYVERNA THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · fourth_quarter · RR
Issues related to developing cell therapies for patients.
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to home care and hospice, telehealth, and Medicare reimbursement.
Issues related to regulations and legislative proposals affecting reimbursement and staffing for home care agencies, home care and hospice; Issues related to Medicaid budget reconciliation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CHATTEM, INC. DBA OPELLA via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments (H.R. 4273/S. 2292); Issues related to S. 2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches; Issues related to the Continuing Appropriations and Extensions Act, 2026 (H.R. 5371).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELLDEX THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to NIH-funded eosinophilic gastrointestinal disease research; Issues related to mast cell conditions and therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including in Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587); Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 (H.R. 5342/S. 2354); Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 (H.R. 3944); Reauthorization proposals in The SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R.2483/S. 2121).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to utilization management and changes to Medicare Part D; Issues related to the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304/S. 2587).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Medicaid, hospital reimbursement, Childrens Hospital GME, Disproportionate Share Hospital payments, and site-neutral payments; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to health care workforce.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to hospital reimbursement, including sequestration; Issues related to prescription drug pricing and surprise billing; Issues related to 1115 Medicaid Waivers; Issues related to telehealth, maternal health, freestanding ERs, and health care workforce.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · third_quarter · Q3
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUPANG, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Advancing economic development goals through Coupangs expansion in current and new markets.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to advanced manufacturing, drug shortages, and pharmaceutical supply chains; Issues related to S.1784 - MAPS Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues regarding smoking cessation; Issues regarding FY26 appropriations bill reports for Labor-HHS and Ag-FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice.
Issues related to regulations and legislative proposals affecting reimbursement and staffing for home care agencies, home care and hospice; Issues related to Medicaid budget reconciliation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CHATTEM, INC. DBA OPELLA via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CELLDEX THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to NIH-funded eosinophilic gastrointestinal disease research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTUS HEALTH SYSTEM via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Children's Hospital GME funding; Implementation of the Consolidated Appropriations Act, 2023 (P.L. 117-328); Fiscal Year 2026 Appropriations.
Issues related to Medicaid, hospital reimbursement, Children's Hospital GME, Disproportionate Share Hospital (DSH) payments, and site-neutral payment, rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to health care workforce.
Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs, hospital reimbursement, including sequestration, prescription drug pricing, Surprise billing, telehealth, 1115 Medicaid Waiver, health care workforce, maternal health, and freestanding ERs.
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; Issues related to H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to utilization management and changes to Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · second_quarter · Q2
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES PHARMACOPEIAL CONVENTION via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to the Pandemic and All-Hazards Preparedness Act (P.L. 109-417)(PAHPA) reauthorization; Issues related to the pharmaceutical supply chain, drug shortages, advanced manufacturing, and pharmaceutical standards.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice.
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues regarding smoking cessation; FY26 appropriations bill reports for Labor-HHS and Ag-FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHATTEM, INC. DBA OPELLA via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to behavioral health services, prescription drug monitoring programs, care coordination and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; SUPPORT Act reauthorization proposals, including H.R. 2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues pertaining to Medicare Advantage compensation, agent and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AGING RESEARCH via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to utilization management and changes to Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · Q1
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELLDEX THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · RR
Issues related to biotechnology policy.
CHATTEM, INC. DBA OPELLA via AKIN GUMP STRAUSS HAUER & FELD
2025 · first_quarter · RR
Issues related to non-prescription drug and dietary supplement policy.
TEXAS ASSOCIATION FOR HOME CARE & HOSPICE via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, 80/20 rule impact on HCBS, and legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; H.R.8114 - To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services.
Issues related to home care and hospice, telehealth, Medicare reimbursement, workforce, legislative and regulatory proposals affecting home care and hospice; H.R.547/S.100 - Better Care Better Jobs Act; H.R.5159/S.2137 - Preserving Access to Home Health Act of 2023; S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act; H.R.4531 - Support for Patients and Communities Reauthorization Act; H.R.4099 - RECONNECTIONS Act of 2023; implementation of Fiscal Year CJS and Labor-HHS appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
AMERILIFE GROUP, LLC via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues pertaining to Medicare Advantage compensation, agent, and broker policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · fourth_quarter · Q4
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to behavioral health services, prescription drug monitoring programs, 988 Suicide and Crisis Lifeline, care coordination and veteran mental health; S.4795 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S.3393 - SUPPORT for Patients and Communities Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
ALKEUS PHARMACEUTICALS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2024 · third_quarter · Q3
Issues related to Stargardt disease and rare disease therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Medicaid, hospital reimbursement, Childrens Hospital GME, Disproportionate Share Hospital payments, and site-neutral payments; Issues related to rural health, including Low-Volume Hospital and Medicare Dependent Hospital programs; Issues related to telehealth; Issues related to the health care workforce; Issues related to hospital reimbursement, rural health, and impact to low-income populations; Issues related to ACA premium assistance.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE